# A Study to Compare the Efficacy of QAV680 Against Placebo in Treating Seasonal Allergic Rhinitis in an Environmental Exposure Chamber

> **NCT00784732** · PHASE2 · COMPLETED · sponsor: **Novartis** · enrollment: 44 (actual)

## Conditions studied

- Seasonal Allergic Rhinitis

## Interventions

- **DRUG:** QAV680
- **DRUG:** QAV680
- **DRUG:** Mometasone Furoate

## Key facts

- **NCT ID:** NCT00784732
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2016-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00784732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00784732, "A Study to Compare the Efficacy of QAV680 Against Placebo in Treating Seasonal Allergic Rhinitis in an Environmental Exposure Chamber". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00784732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*